Arlington Aging Study

ConditionAging
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorThe University of Texas at Arlington

About this trial

The goal of this observational study is to learn about the mechanisms causing functional decline with age, using magnetic resonance imaging, exercise science, integrative physiology, neuroscience, and remote monitoring.

Specific aims include:

Aim 1: Advance knowledge of the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.

Aim 2: Determine the effects of personal and societal factors on aging.

Aim 3: Examine the influence of racial/ethnic and sex differences on the biology of aging and its impact on the prevention, progression, and prognosis of disease and disability.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Adult men and women currently living in Tarrant County will be contacted through IRB approved flyers, targeted ads (social media), and/or word-of-mouth.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

770 Participants
are grouped into 1 trial group
Group A: Older Adults

Trial outcomes

Primary outcomes

1

Sense of Smell

Olfactory Testing will be assessed using the NIH Toolbox Odor Identification cards. After scratching a card and sniffing from each sample, respondents will be asked to choose the best match for each odor from pictures representing the odor sources.

Time frame
Baseline
2

Blood Pressure

Blood Pressure will be measured in the sitting position using an automated blood pressure monitor. After sitting blood pressure measurements, participants will be asked to stand up to measure standing blood pressure.

Time frame
Baseline
3

Street Address

Geographic information systems will assign a geocode to each participant's home address, providing latitude, and longitude coordinates based on the provided street address.

Time frame
Baseline
4

Ankle Brachial Index

The Ankle Brachial Index will be noninvasively assessed using the Smartdop XT device (Koven Technology, Inc.).

Time frame
Baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.